Ergebnis der Suchanfrage nach L&amp

Universum Communications Switzerland AG

Universum Swiss Study offer insights from the largest survey capturing trends shaping Switzerland's talent landscape and their most attractive Employers.

Zurich, Switzerland (ots) - Universum, the world's leading provider of talent research and employer branding expertise, is excited to share the latest findings from the largest Talent Survey in Switzerland. Conducted meticulously, the 2025 survey offers unprecedented insights into the preferences and aspirations of ...

Designwerk Technologies AG

5

Designwerk. Press release Snow plow endurance test in the Swiss Alps

BIAL SA

BIAL Announces Oral Presentation at GBA1 Meeting 2025

Porto, Portugal (ots/PRNewswire) - BIAL, an innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, today announced that it will give an oral presentation on its potential disease-modifying compound, BIA 28-6156, at the GBA1 Meeting 2025 being held June 5-7, 2025, in Montreal, Canada. The GBA1 Meeting 2025 is hosted by McGill University, focusing on all aspects of GBA1 research, from basic ...

Juice Technology AG

Press release: Juice congratulates: World record ride with the J+ BOOSTER 2

Schweizerischer Nationalfonds / Fonds national suisse

When political leaders' personalities threaten democracy

Bern (ots) - By combining electoral data with psychological assessments, political scientists have shown that the polarisation of our societies largely stems from the problematic personalities of some elected representatives. The personalities of politicians seem to directly impact the polarisation of society. With support from the Swiss National Science Foundation (SNSF), a team from the University of Lausanne, led by ...

BIAL SA

BIAL Announces First Patient Out in its Phase 2 Clinical Trial of BIA 28-6156 - a Novel Therapy for GBA1 Parkinson's Disease

Porto, Portugal (ots/PRNewswire) - BIAL, a hundred-year-old innovation-driven biopharmaceutical company focused on neurosciences and rare diseases, announced that the first patient has completed the full dose regimen in the ACTIVATE Phase 2 study. BIA 28-6156 is a first-in-class, small molecule for once-daily oral ...

Schweizerischer Nationalfonds / Fonds national suisse

Men who conform to traditional gender roles are at a higher risk of suicide

Bern (ots) - Men commit suicide much more often than women. Those who want to live up to the traditional male image of strength and independence are particularly at risk. Prevention measures should focus more on them in future. The global suicide rate among men is between two and four times that of women, including in Switzerland. One reason for this considerable ...

Grünenthal Group

Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain

Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...

INFOSYS

Infosys: Strong performance with broad based revenue growth in CC of 3.1% sequentially and 3.3% YoY

Bengaluru, India (ots/PRNewswire) - FY25 revenue guidance revised to 3.75%-4.50%; Margin guidance retained at 20%-22% Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered broad based growth performance with $4,894 million in Q2 revenues, sequential growth of 3.1% and year on year growth of 3.3% in ...

INEOS

INEOS QUATTRO FINANCE 2 PLC ANNOUNCES CASH TENDER OFFER FOR ANY AND ALL OF ITS 3 3/8 % SENIOR SECURED NOTES DUE 2026

London (ots/PRNewswire) - THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE MARKET ABUSE REGULATION (EU) 596/2014, AS AMENDED (AND INCLUDING AS IT FORMS PART OF UNITED KINGDOM DOMESTIC LAW BY VIRTUE OF THE ...

Medasense Biometrics Ltd.

Medasense Announces a Strategic Agreement With Global Medical Company, Nihon Kohden Corporation

Ramat Gan, Israel (ots/PRNewswire) - Medasense, a global leader in pain monitoring solutions, is proud to announce a strategic partnership with Nihon Kohden for the exclusive distribution of its revolutionary pain monitoring device in Japan. This partnership is intended to transform pain management practices across Japanese healthcare facilities, offering a significant ...

Democracy News Alliance

Researchers: The future of democracy is on the ballot in Europe

OceanCare

Need for Global Ban on Solar Geoengineering

Debate at UN environmental summit highlights need for global ban on solar geoengineering - Switzerland ultimately withdrew its resolution on solar radiation modification at the Sixth UN Environment Assembly (UNEA-6) after governments could not even reach consensus on a knowledge repository for the controversial technologies. - The resolution went in several directions during an intense set of negotiations, with different ...

Johnson & Johnson Biosense Webster

Biosense Webster Announces CE Mark approval in Europe for VARIPULSE™ Pulsed Field Ablation (PFA) Platform

Irvine, Calif. (ots/PRNewswire) - - Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow. - Integrated with the world's leading CARTO™ 3D Cardiac Mapping System for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ...

OceanCare

PRESS RELEASE: Protecting marine ecosystems and geoengineering Pandora’s box on the agenda of UN environment ministers this week in Nairobi

The world’s environment ministers are meeting in Nairobi, Kenya this week for the sixth UN Environment Assembly to discuss how multilateralism can help tackle the triple planetary crisis of climate change, loss of nature and biodiversity, and pollution and contamination. OceanCare is very concerned that a ...

OceanCare

Clean-washing? Plastic clean-up tech not all it seems on the surface

CLEAN-UPS OR CLEAN-WASHING? Environmental organisations claim Plastic clean-up tech not all it seems on the surface LONDON/ZURICH, 6th November 2023: A new report from the Environmental Investigation Agency (EIA) and OceanCare highlights the damaging impacts of ‘quick fix’ ocean clean-up ...

Schweizerischer Nationalfonds / Fonds national suisse

Phosphorous - too much in lakes, too little in the soil

Bern (ots) - Over-fertilised waterways, impoverished soils: the use of phosphorous in agriculture is creating a dilemma, and it all began thousands of years ago. This has been verified by an analysis funded by the SNSF. It is well known that phosphorous from agricultural fertilisation and wastewater is harmful to lakes. But the entry of phosphorous into water is also contributing to the scarcity of this substance, which ...

Takeda

Takeda Receives Positive CHMP Opinion Recommending Approval of Lanadelumab for Routine Prevention of Recurrent Attacks of Hereditary Angioedema (HAE) in Patients Aged 2 years and Older

Zurich (ots/PRNewswire) - - If Approved, Lanadelumab Will be the First Long-Term Prophylactic Treatment of HAE Available in the EU for Patients Under the Age of Six. - Positive Opinion Based on Pivotal Study SHP643-301, Evaluating the Safety Profile and Pharmacokinetics (PK) of Lanadelumab, in Combination with ...

Johnson & Johnson Vision

Johnson & Johnson Vision announces launch of ELITA™ Platform to Correct Myopia with New SILK Procedure at the European Society of Cataract and Refractive Surgeons Congress

London (ots/PRNewswire) - Next-generation laser vision correction provides next-day results and recovery1,2 - The next-generation ELITATM Femtosecond Laser to correct myopia with the new SILK procedure** - The latest innovation in extended depth of focus (EDOF) intraocular lenses (IOLs) will be shared with invited ...

Schweizerischer Nationalfonds / Fonds national suisse

Stacking - a route to higher-performance solid-state batteries

Grünenthal Group

Grünenthal’s resiniferatoxin receives Breakthrough Therapy Designation from U.S. FDA for pain associated with osteoarthritis of the knee

Aachen (ots) - - Knee osteoarthritis is a progressive condition affecting over 360 million people worldwide and may have severe symptoms, including pain. - Grünenthal is running a global Phase III programme to investigate the efficacy and safety of intra-articular injections of resiniferatoxin, a non-opioid ...

CSI Christian Solidarity International

Save Karabakh Coalition calls on Switzerland to act to protect besieged Armenians

INFOSYS

Infosys: Industry leading FY23 revenue growth of 15.4% with healthy 21.0% operating margins

Bengaluru, India (ots/PRNewswire) - Revenue growth guidance of 4%-7% and operating margin guidance of 20%-22% for FY24 Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, delivered $18.2 billion in FY23 revenues with industry-leading growth of 15.4% in constant currency and operating margins of 21.0%. Growth ...

Schweizerischer Nationalfonds / Fonds national suisse

Traffic noise - the enemy of our brains